Who invested in Zelos Therapeutics?
Zelos Therapeutics's investors include BDC Capital, VenGrowth, Genesys Capital and Seaflower Ventures.
United States · Seed startup
Funding summaryUpdated 26 Oct 2026
$11Mraised across 4 rounds since 2004, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $2.8M sold, first sale Aug 2011
No investor was named in the report.
Reported by sec.govSEC filing: $922K sold, first sale May 2010
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Mar 2009
From a historical funding record
From the SEC filings it signed: 1 on the team.
On the board, as filediAlex BarkasCynthia LavoieJoseph Zakrzewski
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Zelos Therapeutics's investors include BDC Capital, VenGrowth, Genesys Capital and Seaflower Ventures.
Zelos Therapeutics has raised $11M across 4 rounds since 2004.
Zelos Therapeutics's most recent round was a Seed of $2.8M in Aug 2011.
Zelos Therapeutics's largest round on record is $5.5M (Series A), in Oct 2004.
Zelos Therapeutics's first round on record, in Oct 2004, was backed by BDC Capital, VenGrowth and Genesys Capital and 1 others.
Zelos Therapeutics's latest named round is a Seed, in Aug 2011.
Zelos Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.